doi: 10.1126/science.1241214 107 van NoodEVriezeANieuwdorpMFuentesSZoetendalEGde VosWMet al
At the meeting of the Pharmacy Compounding Advisory Committeewhich last month added eight new members, many with ties to telehealth companies and wellness clinicsFDA researchers argued that the scientific evidence supporting BPC-157 was weak
Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer
That is where BPC 157 truly enters the conversation, and its a game-changer
4, the three most frequently reported SOC categories were "Gastrointestinal disorders," "General disorders and administration site conditions," and "Investigations." Notably, while "Injury, poisoning, and procedural complications" and "Nervous system disorders" demonstrated higher reporting frequencies compared to other SOCs, these associations did not reach statistical significance in our analysis, suggesting potential reporting bias or confounding factors that warrant further investigation